

Esta criptomoneda no está listada para trading o servicios en Gate.
Gráfico del precio en vivo de CDbio (MCD)
Precio del día de CDbio (MCD)
El precio de CDbio (MCD) hoy es de €0.01131 , con un volumen de trading en 24 horas de €5.84 . Como resultado, CDbio (MCD) tiene una capitalización de mercado de -- , lo que le otorga una dominancia de mercado del 0.00037%. El precio de CDbio (MCD) se movió un -0.051% en las últimas 24 horas.
Datos de precios de MCD
- Volumen en 24 h€5.84
- Máximo histórico (ATH)€14.93
- Máximo en 24 h€0.01132
- Mínimo histórico (ATL)€0.01123
- Mínimo en 24 h€0.01131
Datos de capitalización de mercado de MCD
- Valoración totalmente diluida€11.31M
- El sentimiento del mercadoNeutral
Suministro de MCD
- Suministro Total1B MCD
- Suministro máximo1B MCD
Indicadores de credibilidad de CDbio (MCD)
55.65
Puntuación de fiabilidad
PercentilBTM 65%
Acerca de CDbio ( MCD )
Contrato

0xc66cdac...e90ce8d5b
Exploradores
etherscan.io
Sitio Web
cdbio.global
Comunidad
CDBIO is a medical foundation based in the Republic of Seychelles that provides molecularmedical/healthcare services based on advanced molecular physics.
The world's first commercial research co-worker, Yasama Yasuhiko (Yasama), the CEO of Idea International, is working at the Tohoku Univ Research and Analytical Center for Giant Molecular Studies, currently CTO of the CDBIO Foundation.
Molecular sensors using lithium-resistant fullerene are extremely high-precision technologies that allow one electron to flow per molecule and can diagnose diseases and monitor health conditions according to medication effects. Based on this, it is a future advanced medical technology that enables customized prescriptions and treatments optimized for patient characteristics.
Based on this technology, CDBIO is working on the Molecular Medical & Healthcare Platform to create the world's only blockchain healthcare ecosystem that combines the expertise of global molecular physics and electrochemical scholars with the collective intelligence of professional medical communities and patient communities.
Based on this molecular-medical/healthcare platform, we want to help overcome diseases by early diagnosis of all diseases and providing optimized personalized medical services to individual patients, and further contribute to human health and prolongation through disease prevention and systematic health care.